null Option on Mesoblast

MESO Stock  USD 15.62  3.28  26.58%   
Mesoblast's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 1.12 with a put-to-call open interest ratio of 0.21 over 41 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 3.8 K, with calls trading at the volume of 4.3 K. This yields a 0.88 put-to-call volume ratio.

Open Interest Against October 17th 2025 Option Contracts

The chart above shows Mesoblast's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Mesoblast's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Mesoblast's option, there is no secondary market available for investors to trade.

Mesoblast Maximum Pain Price Across 2025-10-17 Option Contracts

Max pain occurs when Mesoblast's market makers reach a net positive position across all Mesoblast's options at a strike price where option holders stand to lose the most money. By contrast, Mesoblast's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Mesoblast

Analyzing Mesoblast's in-the-money options over time can help investors to take a profitable long position in Mesoblast regardless of its overall volatility. This is especially true when Mesoblast's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Mesoblast's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Mesoblast's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Mesoblast lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Mesoblast's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Mesoblast contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Mesoblast Stock moves the wrong way.

Mesoblast In The Money Call Balance

When Mesoblast's strike price is surpassing the current stock price, the option contract against Mesoblast stock is said to be in the money. When it comes to buying Mesoblast's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Mesoblast are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Mesoblast Current Options Market Mood

Mesoblast's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Mesoblast Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Mesoblast's options investors are not very successful. Mesoblast's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Mesoblast contract

Base on the Rule 16, the options market is currently suggesting that Mesoblast will have an average daily up or down price movement of about 0.07% per day over the life of the 2025-10-17 option contract. With Mesoblast trading at USD 15.62, that is roughly USD 0.0109. If you think that the market is fully incorporating Mesoblast's daily price movement you should consider buying Mesoblast options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Mesoblast options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Mesoblast calls. Remember, the seller must deliver Mesoblast stock to the call owner when a call is exercised.

Mesoblast Option Chain

When Mesoblast's strike price is surpassing the current stock price, the option contract against Mesoblast stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Mesoblast's option chain is a display of a range of information that helps investors for ways to trade options on Mesoblast. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Mesoblast. It also shows strike prices and maturity days for a Mesoblast against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
MESO251017C00030000330.00.05 - 0.650.55Out
Call
MESO251017C00025000325.00.7 - 1.050.7Out
Call
MESO251017C00024000024.00.8 - 1.10.9Out
Call
MESO251017C0002300020023.00.9 - 1.31.1Out
Call
MESO251017C000220001322.01.05 - 1.50.85Out
Call
MESO251017C0002100014521.01.2 - 1.650.41Out
Call
MESO251017C00020000588720.01.4 - 1.81.75Out
Call
MESO251017C0001900019319.01.6 - 2.10.59Out
Call
MESO251017C0001800089018.01.85 - 2.52.31Out
Call
MESO251017C0001700026417.02.2 - 2.72.47Out
Call
MESO251017C0001600056716.02.55 - 3.02.65Out
Call
MESO251017C0001500056615.03.1 - 3.53.22In
Call
MESO251017C0001400052614.03.4 - 3.93.7In
Call
MESO251017C0001300040613.03.9 - 4.44.3In
Call
MESO251017C00012000196912.04.5 - 4.94.9In
Call
MESO251017C000110009611.05.2 - 5.85.5In
Call
MESO251017C0001000052210.06.0 - 6.36.2In
Call
MESO251017C0000900039.06.2 - 7.82.65In
Call
MESO251017C000080001238.07.6 - 8.13.4In
Call
MESO251017C00007000157.08.4 - 9.78.4In
Call
MESO251017C00006000246.08.7 - 10.44.8In
Call
MESO251017C000050001215.010.0 - 12.56.8In
 Put
MESO251017P00030000030.013.9 - 15.713.9In
 Put
MESO251017P00025000025.09.7 - 10.89.7In
 Put
MESO251017P00024000024.08.9 - 10.38.9In
 Put
MESO251017P00023000023.08.1 - 9.38.1In
 Put
MESO251017P00022000022.07.1 - 8.17.1In
 Put
MESO251017P00021000021.06.4 - 7.36.4In
 Put
MESO251017P000200003320.05.6 - 6.79.9In
 Put
MESO251017P00019000019.04.6 - 5.84.6In
 Put
MESO251017P00018000118.04.0 - 4.95.8In
 Put
MESO251017P00017000017.03.3 - 4.73.3In
 Put
MESO251017P0001500020615.02.3 - 2.92.3Out
 Put
MESO251017P000140001114.01.8 - 2.853.55Out
 Put
MESO251017P000130001613.01.3 - 2.254.2Out
 Put
MESO251017P00012000179212.01.1 - 2.051.2Out
 Put
MESO251017P000110002711.00.7 - 1.850.9Out
 Put
MESO251017P0001000022510.00.45 - 1.250.65Out
 Put
MESO251017P0000900029.00.0 - 1.351.35Out
 Put
MESO251017P00008000268.00.0 - 0.80.6Out
 Put
MESO251017P000060002756.00.0 - 4.80.35Out

Mesoblast Corporate Management

LLB BComJoint SecretaryProfile
Justin BSHead ManufacturingProfile
Marcelo SantoroChief OfficerProfile
Roger BAHead DisordersProfile
Fiona SeeSenior ResearchProfile
MS MBAChief OfficerProfile
BSc LLBGen ExecProfile
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.28)
Revenue Per Share
0.05
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.05)
Return On Equity
(0.21)
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.